SCHEMBL30990436

SCHEMBL30990436

Nc1ncnc2c1c(-c1noc(C3CC3)c1-c1ccccn1)nn2C1CC(C(=O)O)C1

nearest known ligand 0.54

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 16/20 0.54
▸ LCK P06239 1/20 0.42
▸ SRC P12931 1/20 0.42
▸ TEK Q02763 1/20 0.42
▸ EGFR P00533 2/20 0.41
▸ BTK Q06187 1/20 0.41
▸ KDR P35968 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30990430 0.90 RET (0.53) RETEGFRBTK
SCHEMBL30990450 0.88 RET (0.51) RETEGFRBTKKDR
SCHEMBL30990426 0.88 RET (0.51) RETEGFRBTK
SCHEMBL30990441 0.84 RET (0.46) RETEGFRBTKKDR
SCHEMBL30990442 0.83 RET (0.49) RETLCKSRCTEKEGFR
SCHEMBL30990471 0.83 RET (0.53) RETLCKSRCTEKBTK
SCHEMBL30990486 0.83 RET (0.53) RETLCKSRCTEKBTK
SCHEMBL30990418 0.82 RET (0.54) RETSRCEGFRKDR
SCHEMBL30990449 0.82 RET (0.54) RETSRCEGFRKDR
SCHEMBL30990455 0.79 RET (0.53) RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665720-A2 ISOINDOLINONE GLUTARIMIDE AND PHENYL GLUTARIMIDE ANALOGS AS DEGRADERS OF RET KINASE Bristol-Myers Squibb Company (US) 2025-12-24 — — EP disclosed
WO-2024173832-A2 ISOINDOLINONE GLUTARIMIDE AND PHENYL GLUTARIMIDE ANALOGS AS DEGRADERS OF RET KINASE BRISTOL-MYERS SQUIBB COMPANY (US) 2024-08-22 — — WO disclosed
Send feedback